ANTI-VEGF SINGLE-DOMAIN ANTIBODY AND USE THEREOF Application EP-4032905-A4 European Patent Office 08 Nov 2023
METHOD OF REDUCING CST FLUCTUATION IN NEOVASCULAR AMD BY A RECOMBINANT ADENO-ASSOCIATED… Application WO-2023158990-A1 World Intellectual Property Organisation (WIPO) 24 Aug 2023
Long-acting VEGF inhibitors for intraocular neovascularization Grant US-11576948-B2 United States of America 14 Feb 2023
Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents Grant US-11524053-B2 United States of America 13 Dec 2022
Long-acting VEGF inhibitors for intraocular neovascularization Grant US-11433118-B2 United States of America 06 Sep 2022
Long-acting VEGF inhibitors for intraocular neovascularization Grant US-11382955-B2 United States of America 12 Jul 2022
METHODS AND COMPOSITIONS FOR TREATMENT OF ANGIOGENIC DISORDERS USING ANTI-VEGF AGENTS Application EP-3743091-A4 European Patent Office 15 Dec 2021
Lebecetin, a C-type lectin, as neovascularization inhibitor Grant US-11191807-B2 United States of America 07 Dec 2021
LEBECETIN, A C-TYPE LECTIN, AS NEOVASCULARIZATION INHIBITOR Application WO-2018108945-A1 World Intellectual Property Organisation (WIPO) 21 Jun 2018